2024-09-19 - Analysis Report
## Merck & Co Inc (MRK) Stock Analysis Report

**Company Overview:** Merck & Co. Inc is a global pharmaceutical company that develops and markets a wide range of prescription medicines, vaccines, and animal health products.

**Performance Analysis:**

**1. Performance vs S&P 500 (VOO):** 
* **Cumulative Return:** 83.74% for MRK, 129.06% for VOO.
* **Relative Performance:** MRK is lagging behind VOO with a cumulative return difference of -45.32%. This puts MRK at the 37.91 percentile relative to its historical performance against VOO. 

**2. Recent Price Movements:**
* **Closing Price:** $118.03
* **5-Day Moving Average:** $116.36
* **20-Day Moving Average:** $116.59
* **60-Day Moving Average:** $120.26

**3. Technical Indicators:**
* **RSI:** 55.23, indicating a neutral market sentiment. 
* **PPO:** 0.28, suggesting a potential buy signal.
* **Delta_Previous_Relative_Divergence:** 4.63, indicating a short-term upward trend.
* **Expected Return:** 14.04%, representing the potential 5-year return on current investment.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-05 | 2.15 | 16.11 B$ |
| 2024-05-03 | 1.88 | 15.78 B$ |
| 2023-11-03 | 1.87 | 15.96 B$ |
| 2023-08-07 | -2.35 | 15.04 B$ |
| 2024-08-05 | -2.35 | 15.04 B$ |

The most recent earnings report on 2024-08-05 exceeded analyst estimates for both EPS and revenue. This positive performance indicates strong demand for the company's products and a healthy financial position.

**Overall Analysis:**

Merck & Co. Inc (MRK) shows promising signs of growth and stability despite lagging slightly behind the S&P 500. Its recent earnings beat expectations, suggesting a positive outlook. Technical indicators like RSI and PPO indicate a neutral to bullish market sentiment, suggesting a potential buy opportunity. However, investors should consider the historical underperformance compared to VOO and monitor market trends closely. 
